Literature DB >> 26757960

Valuing inter-sectoral costs and benefits of interventions in the healthcare sector: methods for obtaining unit prices.

Ruben M W A Drost1, Aggie T G Paulus1, Dirk Ruwaard1, Silvia M A A Evers1,2.   

Abstract

INTRODUCTION: There is a lack of knowledge about methods for valuing health intervention-related costs and monetary benefits in the education and criminal justice sectors, also known as 'inter-sectoral costs and benefits' (ICBs). The objective of this study was to develop methods for obtaining unit prices for the valuation of ICBs.
METHODS: By conducting an exploratory literature study and expert interviews, several generic methods were developed. The methods' feasibility was assessed through application in the Netherlands. Results were validated in an expert meeting, which was attended by policy makers, public health experts, health economists and HTA-experts, and discussed at several international conferences and symposia.
RESULTS: The study resulted in four methods, including the opportunity cost method (A) and valuation using available unit prices (B), self-constructed unit prices (C) or hourly labor costs (D). DISCUSSION: The methods developed can be used internationally and are valuable for the broad international field of HTA.

Entities:  

Keywords:  costs and cost analysis; criminal justice; education; healthcare sector; inter-sectoral costs and benefits; valuation methods

Mesh:

Year:  2016        PMID: 26757960     DOI: 10.1586/14737167.2016.1141679

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  8 in total

1.  MUW researcher of the month.

Authors:  Susanne Mayer
Journal:  Wien Klin Wochenschr       Date:  2018-11       Impact factor: 1.704

2.  Unit Costs of Delinquent Acts for Use in Economic Evaluations.

Authors:  Vivian T Reckers-Droog; Maartje Goorden; Marcel G W Dijkgraaf; Hester V Van Eeren; Kathryn E McCollister; Leona Hakkaart-van Roijen
Journal:  J Ment Health Policy Econ       Date:  2019-06-01

Review 3.  Conceptualising 'Benefits Beyond Health' in the Context of the Quality-Adjusted Life-Year: A Critical Interpretive Synthesis.

Authors:  Lidia Engel; Stirling Bryan; David G T Whitehurst
Journal:  Pharmacoeconomics       Date:  2021-08-23       Impact factor: 4.981

Review 4.  Health-Related Resource-Use Measurement Instruments for Intersectoral Costs and Benefits in the Education and Criminal Justice Sectors.

Authors:  Susanne Mayer; Aggie T G Paulus; Agata Łaszewska; Judit Simon; Ruben M W A Drost; Dirk Ruwaard; Silvia M A A Evers
Journal:  Pharmacoeconomics       Date:  2017-09       Impact factor: 4.981

5.  Scaling-up primary health care-based prevention and management of heavy drinking at the municipal level in middle-income countries in Latin America: Background and protocol for a three-country quasi-experimental study.

Authors:  Peter Anderson; Amy O'Donnell; Eileen Kaner; Antoni Gual; Bernd Schulte; Augusto Pérez Gómez; Hein de Vries; Guillermina Natera Rey; Jürgen Rehm
Journal:  F1000Res       Date:  2017-03-23

Review 6.  Harmonization issues in unit costing of service use for multi-country, multi-sectoral health economic evaluations: a scoping review.

Authors:  Claudia Fischer; Susanne Mayer; Nataša Perić; Judit Simon
Journal:  Health Econ Rev       Date:  2022-08-03

7.  The Relative Importance of Education and Criminal Justice Costs and Benefits in Economic Evaluations: A Best-Worst Scaling Experiment.

Authors:  Irina Pokhilenko; Luca M M Janssen; Mickael Hiligsmann; Silvia M A A Evers; Ruben M W A Drost; Aggie T G Paulus; Leonarda G M Bremmers
Journal:  Pharmacoeconomics       Date:  2020-10-07       Impact factor: 4.981

8.  Establishing a comprehensive list of mental health-related services and resource use items in Austria: A national-level, cross-sectoral country report for the PECUNIA project.

Authors:  Claudia Fischer; Susanne Mayer; Nataša Perić; Judit Simon
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.